CNS Pharmaceuticals Inc. (CNSP)
Market Closed
30 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
4. 85
-0.15
-3%
$
3.33M Market Cap
- P/E Ratio
- Div Yield
3,075 Volume
0 Eps
$ 5
Previous Close Investors:
Want to track CNSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript
CNS Pharmaceuticals, Inc. ( CNSP ) Shareholder/Analyst Call November 17, 2025 12:00 PM EST Company Participants John Climaco - CEO, President & Director Christopher Downs - Chief Financial Officer Presentation John Climaco CEO, President & Director Welcome, everyone. The Annual Meeting of the Stockholders of CNS Pharmaceuticals, Inc. is hereby convened and called to order.
Seekingalpha | 8 months ago
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?
CNS Pharmaceuticals (NASDAQ: CNSP ) stock is heading lower on Tuesday after the clinical-pharmaceutical company announced an expansion to its pipeline. CNS Pharmaceuticals has acquired an exclusive license and the intellectual property rights to TPI 287.
Investorplace | 2 years ago
